Navigation Links
Using Product Marketing to Launch Drugs That Outperform the Competition
Date:1/17/2008

CHAPEL HILL, N.C., Jan. 17 /PRNewswire/ -- With so much riding on new product development and market launch, the pharma industry is continually seeking to improve the expensive and time-consuming process. To launch drugs that outperform the competition, leading firms are focusing more marketing resources on the early stages of development, according to research from benchmarking leader Best Practices, LLC.

For instance, while many companies limit marketing spending in early stages to 10 percent of total pre-launch spending, organizations with consistently high product performance reported early stage spending levels as high as 27 percent, according to the study.

"Early marketing insights pay off at launch," said Cameron Tew, senior manager of research and publishing at Best Practices, LLC. "Companies that have achieved faster and higher sales uptake with new products are committing sufficient marketing resources as early as the pre-clinical phase."

The 169-page report, "Launching Pharmaceutical Megabrands: Best Practices in Marketing Blockbusters," includes 96 best practices drawn from surveys and interviews with 24 executives at more than 15 leading pharmaceutical and biotechnology companies such as Pfizer, Merck, Sanofi-Aventis, GlaxoSmithKline, Eli Lilly, Amgen, Boehringer-Ingelheim and Novartis.

For a complimentary download of a study excerpt, visit http://www3.best-in-class.com/rr900.htm .

Marketing and branding decision-makers can use the report to gather insights on development topics ranging from marketing investment and expense patterns to thought leader development for high-potential products. In addition, the report includes marketing success stories for 16 of the world's top selling drugs.

Some of the study findings include:

-- Companies that consistently launch blockbuster drugs foster a culture

that actively supports productive medical and marketing collaborations.

-- Top-performing benchmark partners conduct a wide spectrum of market

research, from pre-clinical to post-launch.

-- Leading companies spend gradually and selectively on high impact pre

marketing activities to create awareness, demand and preferences for

their new products.

To learn more about this study, review a complimentary report summary at http://www3.best-in-class.com/rr900.htm .

To drill down on the metrics and best practices presented in this report, contact Cameron Tew at 919-767-9246 or ctew@best-in-class.com .

ABOUT BEST PRACTICES, LLC

Best Practices, LLC is a research and consulting firm that conducts work based on the principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. For more information, call (919) 403-0251 or visit http://www.best-in-class.com .


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Holiday Visits Nudge Many Towards Senior Housing Decision
2. Researchers seek to make cavity-causing bacteria self-destruct
3. Winemaking waste proves effective against disease-causing bacteria in early studies
4. Novare Announces Completion of 100th Single Port Laparoscopic Procedure Using RealHand(R) High Dexterity (HD) Instruments
5. Using Early Stage Commercialization Activities to Build Long-Term Success for the Bottom Line
6. Reserve 2008 Budget for Using Quality to Improve the Customer Experience
7. Older Diabetics Using Avandia Face Increased Death Risk
8. Federal Judge Says Sugar Association Suit Accusing Johnson & Johnson of False Advertising to Go Forward
9. UCSF Medical Center using newest high-tech tool for brain disorders
10. Mini transplant patients outcomes similar using related and unrelated donor cells
11. Amneal Receives FDA Approval for Bethanechol Chloride Tablets, USP Using New Expedited FDA Approval Process
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... ... Dudnyk has announced the launch of its new brand identity, called The ... specialty and orphan brands can only be achieved when the needs and beliefs of ... at the heart of a true partnership between our agency and our clients to ...
(Date:4/21/2017)... ... 2017 , ... The VIA Agency , a full-service ... Theravent, Inc. , the makers of a revolutionary new device clinically proven to ... working to expand distribution in anticipation of a national launch. VIA will be ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... campaign, AWARE: A Week of Addiction and Recovery Education, from April 24 to ... and preventing substance use disorders. , The mission of AWARE is to ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... the much anticipated Regional Primary Care Spring Symposium on April 1, 2017 in ... medical community, offering physicians and healthcare providers an opportunity to learn about cutting ...
(Date:4/21/2017)... ... , ... Providing for loved ones before one’s passing is of paramount importance. ... begin. “Now more than ever there are some questions that are far too critical ... said attorney Lisa Edgar Dickman, founder of the Law Offices of Lisa Edgar Dickman. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... platform, the first non-viral gene expression technology that enables ... the eye to address a wide range of ophthalmic ... Medicines and Healthcare products Regulatory Agency (MHRA) to advance ... ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, Chile, ... their offering. ... Latin American pharmaceutical contract manufacturing services market is anticipated to ... registration cost in Latin American countries and continuous economic growth ...
(Date:4/19/2017)... Cardiology devices segment is anticipated to reach the highest market ... segment is likely to create absolute $ opportunity of a ... By the end of 2027, Cardiology Devices segment is projected ... expanding at a CAGR of 18.4% over the forecast period. ... reprocessed medical devices market in terms of revenue ...
Breaking Medicine Technology: